Integra LifeSciences Schedules Conference Call for Wed., August 2 to Discuss Second Quarter 2006 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J.--(BUSINESS WIRE)--July 7, 2006--Integra LifeSciences Holdings Corporation (NASDAQ:IART) has scheduled a conference call for 9:00 AM EST on Wednesday, August 2 to discuss financial results for the second quarter June 30, 2006 and to update forward-looking financial guidance. Financial results for the second quarter 2006 will be announced via a news release issued before the market opens on August 2.
The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward-looking information may be discussed in a question and answer session following the call.
Access to the live call is available by dialing 719-457-2662 or through a webcast via a link provided on Integra's website at www.Integra-LS.com. Access to a replay is available through August 16, 2006 by dialing 719-457-0820 (PIN 3716541) or through the webcast.
Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applications for Integra's products are neurosurgery, reconstructive surgery and general surgery. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Our corporate headquarters are in Plainsboro, New Jersey, and we have manufacturing and research facilities located throughout the world.
Integra LifeSciences Holdings Corporation
Maria Platsis, Vice President, Corporate Development
(609) 936-2333
mplatsis@Integra-LS.com
or
John Bostjancic, Vice President
(609)-936-2239
jbostjancic@integra-ls.com